BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24975429)

  • 1. Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancer.
    Ichinose J; Watanabe K; Sano A; Nagase T; Nakajima J; Fukayama M; Yatomi Y; Ohishi N; Takai D
    Cancer Sci; 2014 Sep; 105(9):1135-41. PubMed ID: 24975429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of PABPN1 phase separation by SNRPD2 drives colorectal cancer cell proliferation and migration through promoting alternative polyadenylation of CTNNBIP1.
    Hu Z; Li M; Chen Y; Chen L; Han Y; Chen C; Lu X; You N; Lou Y; Huang Y; Huo Z; Liu C; Liang C; Liu S; Deng K; Chen L; Chen S; Wan G; Wu X; Fu Y; Xu A
    Sci China Life Sci; 2024 Jun; 67(6):1212-1225. PubMed ID: 38811444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Characterization of Alternative Polyadenylation in Human Cancer.
    Xiang Y; Ye Y; Lou Y; Yang Y; Cai C; Zhang Z; Mills T; Chen NY; Kim Y; Muge Ozguc F; Diao L; Karmouty-Quintana H; Xia Y; Kellems RE; Chen Z; Blackburn MR; Yoo SH; Shyu AB; Mills GB; Han L
    J Natl Cancer Inst; 2018 Apr; 110(4):379-389. PubMed ID: 29106591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
    Kim N; Chung W; Eum HH; Lee HO; Park WY
    PLoS One; 2019; 14(5):e0217196. PubMed ID: 31100099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers.
    Wang L; Lang GT; Xue MZ; Yang L; Chen L; Yao L; Li XG; Wang P; Hu X; Shao ZM
    Theranostics; 2020; 10(23):10531-10547. PubMed ID: 32929364
    [No Abstract]   [Full Text] [Related]  

  • 7. Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.
    Mo ML; Okamoto J; Chen Z; Hirata T; Mikami I; Bosco-Clément G; Li H; Zhou HM; Jablons DM; He B
    PLoS One; 2013; 8(8):e71816. PubMed ID: 23977152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive map of alternative polyadenylation in African American and European American lung cancer patients.
    Zingone A; Sinha S; Ante M; Nguyen C; Daujotyte D; Bowman ED; Sinha N; Mitchell KA; Chen Q; Yan C; Loher P; Meerzaman D; Ruppin E; Ryan BM
    Nat Commun; 2021 Sep; 12(1):5605. PubMed ID: 34556645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide profiling reveals alternative polyadenylation of mRNA in human non-small cell lung cancer.
    Zhang S; Zhang X; Lei W; Liang J; Xu Y; Liu H; Ma S
    J Transl Med; 2019 Aug; 17(1):257. PubMed ID: 31391087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.
    Gao Z; Shi R; Yuan K; Wang Y
    Tumour Biol; 2016 Nov; 37(11):14979-14987. PubMed ID: 27655285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative Polyadenylation Utilization Results in Ribosome Assembly and mRNA Translation Deficiencies in a Model for Muscle Aging.
    Mei H; Boom J; El Abdellaoui S; Abdelmohsen K; Munk R; Martindale JL; Kloet S; Kielbasa SM; Sharp TH; Gorospe M; Raz V
    J Gerontol A Biol Sci Med Sci; 2022 Jun; 77(6):1130-1140. PubMed ID: 35245938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic profiling of poly(A)+ transcripts modulated by core 3' end processing and splicing factors reveals regulatory rules of alternative cleavage and polyadenylation.
    Li W; You B; Hoque M; Zheng D; Luo W; Ji Z; Park JY; Gunderson SI; Kalsotra A; Manley JL; Tian B
    PLoS Genet; 2015 Apr; 11(4):e1005166. PubMed ID: 25906188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
    Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY
    Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lengthening of 3' Untranslated Regions of mRNAs by Alternative Polyadenylation Is Associated With Tumor Progression and Poor Prognosis of Clear Cell Renal Cell Carcinoma.
    Zhang F; Chen L; Li W; Yang C; Xiong M; Zhou M; Kazobinka G; Zhao J; Hou T
    Lab Invest; 2023 Jun; 103(6):100125. PubMed ID: 36889542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyadenylation-dependent control of long noncoding RNA expression by the poly(A)-binding protein nuclear 1.
    Beaulieu YB; Kleinman CL; Landry-Voyer AM; Majewski J; Bachand F
    PLoS Genet; 2012; 8(11):e1003078. PubMed ID: 23166521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer.
    Tischler V; Pfeifer M; Hausladen S; Schirmer U; Bonde AK; Kristiansen G; Sos ML; Weder W; Moch H; Altevogt P; Soltermann A
    Mol Cancer; 2011 Oct; 10():127. PubMed ID: 21985405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PABPN1 shuts down alternative poly(A) sites.
    Simonelig M
    Cell Res; 2012 Oct; 22(10):1419-21. PubMed ID: 22641371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation.
    de Klerk E; Venema A; Anvar SY; Goeman JJ; Hu O; Trollet C; Dickson G; den Dunnen JT; van der Maarel SM; Raz V; 't Hoen PA
    Nucleic Acids Res; 2012 Oct; 40(18):9089-101. PubMed ID: 22772983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PABPN1 aggregation is driven by Ala expansion and poly(A)-RNA binding, leading to CFIm25 sequestration that impairs alternative polyadenylation.
    Guan WL; Jiang LL; Yin XF; Hu HY
    J Biol Chem; 2023 Aug; 299(8):105019. PubMed ID: 37422193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.